Latigo reports Q3 2026 results, names new CEO, adds opioid arm to Phase 3 trialNov 5Quarterly updateCollegium Pharmaceutical, IncLatigo Biotherapeutics
Collegium and Grünenthal settle Nucynta patent litigationOct 19PartnershipCollegium Pharmaceutical, IncGrünenthal
Trial registered testing Jornay PM for ADHD with cannabis use disorder in young peopleSep 24Trial updateCollegium Pharmaceutical, Incmethylphenidate
Collegium cuts 2026 revenue guidance on weaker Nucynta generic pricingAug 6Quarterly updateCollegium Pharmaceutical, Inctapentadol